Cancer and the microbiota
Open accessThe DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Abstract
A host’s microbiota may increase, diminish, or have no effect at all on cancer susceptibility. Assigning causal roles in cancer to specific microbes and microbiotas, unraveling host-microbiota interactions with environmental factors in carcinogenesis, and exploiting such knowledge for cancer diagnosis and treatment are areas of intensive interest. This Review considers how microbes and the microbiota may amplify or mitigate carcinogenesis, responsiveness to cancer therapeutics, and cancer-associated complications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Loss of microbial diversity (dysbiosis) is associated with chronic health conditions (26–28) and cancer (8–10), and is also associated with poor outcomes to certain forms of cancer therapy including allogeneic stem cell transplant (29).”
From Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients (2018) · cites this paper as [8]
In the citing paper
“It has recently emerged that factors beyond tumor genomics influence cancer development and therapeutic responses (4–7), including host factors such as the gastrointestinal (gut) microbiome (8–10).”
From Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients (2018) · cites this paper as [8]
In the citing paper
“their gene count that exceeds the human genome’s gene count by ~100-fold and enables diverse metabolic programming”
From The microbiome and human cancer (2021) · cites this paper as [31]
In the citing paper
“the number of microbes that inhabit the human body (roughly equal to the number of human cells)”
From The microbiome and human cancer (2021) · cites this paper as [31]
In the citing paper
“their effects on host immune system development and activity, including antitumor immunosurveillance (27–31).”
From The microbiome and human cancer (2021) · cites this paper as [31]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Self-citationMetabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Inflammatory Mechanisms in Obesity
Gregor, M. F., & Hotamisligil, G. S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101322 · Cited by 3,754
Research works printed but not linked: 1
- 10.1111/j.1572-0241.2000.01860.x · doi:10.1111/j.1572-0241.2000.01860.x · Paper page
Cited by
Items 701–800 of 1,001
Microbiota in digestive cancers: our new partner?
Lopez, A., Hansmannel, F., Kökten, T., Bronowicki, J., Melhem, H., Sokol, H., & Peyrin‐Biroulet, L. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx087 · Cited by 16
Wang, L., Ke, J., Wang, C., Li, Y., Wu, G., Ding, Q., Luo, Q., Cai, R., Lv, P., Song, T., et al. (2020) · Integrative Cancer Therapies · doi:10.1177/1534735420942587 · Cited by 16
Helicobacter pylori and gastric cancer: a lysosomal protease perspective
Soond, S. M., & Zamyatnin, A. A. (2021) · Gastric Cancer · doi:10.1007/s10120-021-01272-8 · Cited by 16
Havasi, A. D., Sur, D. G., Cainap, S. S., Lungulescu, C.-V., Gavrilaș, L. I., Cainap, C. I., Vlad, C. I., & Bălăcescu, O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031109 · Cited by 17
“At the same time, Fusobacterium nucleatum supports progression via immune evasion and proliferative stimuli [61,62].”
Backgroundvan den Boom, A. L., Lavrijssen, B. D. A., Fest, J., Ikram, M. A., Stricker, B. H. C., van Eijck, C. H. J., & Ruiter, R. (2022) · Cancer Epidemiology · doi:10.1016/j.canep.2022.102120 · Cited by 20
NK cells - Dr. Jekyll and Mr. Hyde in autoimmune rheumatic diseases
Hojjatipour, T., Aslani, S., Salimifard, S., Mikaeili, H., Hemmatzadeh, M., Navashenaq, J. G., Parvin, E. A., Jadidi‐Niaragh, F., & Mohammadi, H. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108682 · Cited by 17
The New Frontier: the Intestinal Microbiome and Surgery
Skowron, K. B., Shogan, B. D., Rubin, D. T., & Hyman, N. (2018) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-018-3744-7 · Cited by 16
Gene Expression Analysis of Human Papillomavirus‐Associated Colorectal Carcinoma
Qiu, Q., Li, Y., Fan, Z., Yao, F., Shen, W., Sun, J., Yuan, Y., Chen, J., Cai, L., Xie, Y., et al. (2020) · BioMed Research International · doi:10.1155/2020/5201587 · Cited by 15
“Evidence from the previous study also supports that microbes play a role in dysregulating the Wnt/β-catenin signaling pathway as a means of tumor initiation [47].”
ResultThe Unfolding Story of ATF6, Microbial Dysbiosis, and Colorectal Cancer
Lavoie, S., & Garrett, W. S. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.10.011 · Cited by 15
Self-citationTargeting the Tumor Microbiota in Cancer Therapy Basing on Nanomaterials
Niu, Y., Feng, J., Ma, J., Xiao, T., & Yuan, W. (2025) · Exploration · doi:10.1002/exp.20210185 · Cited by 26
“Several studies suggest that microbiota can activate NF-𝜅 B or β -catenin pathways, promoting tumor progression [60].”
Targeting Intratumoral Bacteria for Cancer Treatment
Shi, J., Liang, J., Li, Y., Zhang, Z., Sun, J. X., He, Z., Luo, C., Qu, X., Che, X., & Zhang, S. (2025) · Small · doi:10.1002/smll.202505651 · Cited by 15
Intratumoral microbiota: implications for cancer progression and treatment
Xie, Z., Wu, Z., Liu, Y., Gu, Y., Niu, J., & Lv, K. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1551515 · Cited by 23
“Previous studies have shown that the intratumor microbiota can contribute to cancer formation, progression and prognosis (Garrett, 2015; Sepich-Poore et al., 2021; Nejman et al., 2020).”
The role of the microbiome in pancreatic oncogenesis
Daley, D. (2022) · International Immunology · doi:10.1093/intimm/dxac036 · Cited by 15
The difference of human gut microbiome in colorectal cancer with and without metastases
Sun, L., Zhu, Z., Jia, X., Ying, X., Wang, B., Wang, P., Zhang, S., & Yu, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.982744 · Cited by 20
“It is worth emphasizing that there is a complicated relationship between CRC and GM (10).”
BackgroundWang, H., Hu, J., Wu, J., Ji, P., Shang, A., & Li, D. (2022) · Cancers · doi:10.3390/cancers14215394 · Cited by 17
“Neoplastic diseases of the lung are characterized by a number of common features, one of which is an alteration in the amount of intestinal flora [44].”
BackgroundBurkett, W. C., Clontz, A. D., Keku, T. O., & Bae-Jump, V. L. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189000 · Cited by 24
Gorini, F., & Tonacci, A. (2023) · Antioxidants · doi:10.3390/antiox12101898 · Cited by 20
“…or immunosuppressive pathways, although gut–tumor microenvironment crosstalk, especially in non-gastrointestinal cancers, has yet to be fully clari fi ed [30,134]. rapamycin, and autophagy inhibitors, such as chloroquine, [155]) can a winning strategy to prevent or treat human cancer [144,150].”
BackgroundIncreased Risk for Colon Polyps in Patients with Reflux Disease
Sonnenberg, A., Turner, K., & Genta, R. M. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4841-2 · Cited by 16
Xu, J., Yu, X. L., Ye, H., Gao, S., Deng, N., Lu, Y., Lin, H., Zhang, Y., & Lu, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.825358 · Cited by 16
“We provide evidence to support the purpose of focusing on the role of microbiota in changing the balance between host cell proliferation and death in cancer progression (78), especially those bacteria that deploy additional virulence factors such as V.”
BackgroundHepatocellular carcinoma and microbiota: Implications for clinical management and treatment
Spanu, D., Pretta, A., Lai, E., Persano, M., Donisi, C., Mariani, S., Dubois, M., Migliari, M., Saba, G., Ziranu, P., et al. (2022) · World Journal of Hepatology · doi:10.4254/wjh.v14.i7.1319 · Cited by 17
Metabolism of eriocitrin in the gut and its regulation on gut microbiota in mice
Meng, X., Wu, H., Xiong, J., Li, Y., Chen, L., Gu, Q., & Li, P. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1111200 · Cited by 14
“Growing evidence suggests that the occurrence of some diseases, such as obesity (Ley et al., 2005), cancer (Garrett, 2015), and cardiovascular disease (Tang et al., 2017), is related to the imbalance of intestinal microbial.”
BackgroundApplying the design-build-test paradigm in microbiome engineering
Pham, H. L., Ho, C. L., Wong, A., Lee, Y. S., & Chang, M. W. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.03.021 · Cited by 17
The oncomicrobiome: New insights into microorganisms in cancer
Ma, Y., Chen, T., Sun, T., Dilinuer, D., & Xiao, Y. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.107091 · Cited by 16
Bugs as Drugs: Neglected but a Promising Future Therapeutic Strategy in Cancer
Divyashree, M., Prakash, S. K., Aditya, V., Aljabali, A. A. A., Alzahrani, K. J., Azevedo, V., Goés‐Neto, A., Tambuwala, M. M., & Barh, D. (2022) · Future Oncology · doi:10.2217/fon-2021-1137 · Cited by 13
Pani, G. (2023) · Cancers · doi:10.3390/cancers15092583 · Cited by 17
“Shared features of these CRC-associated microorganisms are the potential for direct DNA damage, and/or the capacity of hijacking host cell signaling pathways (such as the Wnt/βcatenin-TCF/LEF axis) so as to promote cell proliferation, resistance to apoptosis, and the release of proinflammatory cytokines [16,19].”
BackgroundGut microbiota in cancer: insights on microbial metabolites and therapeutic strategies
Chen, Y., Wang, X., Ye, Y., & Ren, Q. (2023) · Medical Oncology · doi:10.1007/s12032-023-02249-6 · Cited by 14
“As our understanding of gut microbiota has deepened in recent years, it has been revealed that dysbiosis of intestinal microbiota can precipitate the development of various cancers [2].”
Su, Y., Li, S., Sang, D., & Zhang, Y. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1353940 · Cited by 13
“It has been reported that human microbiome especially Helicobacter pylori, Proteobacteria, Bacteroidetes fragilis and Fusobacterium nucleatum , have been proved to be related to the occurrence and development of some cancers (Schwabe and Jobin, 2013; Garrett, 2015; Liu et al., 2022).”
BackgroundSong, M., Zhang, S., Zhang, Z., Guo, L., Liang, W., Li, C., & Wang, Z. (2024) · mSystems · doi:10.1128/msystems.00602-24 · Cited by 14
“Considerable evidence suggests that IM dysbiosis could lead to several complex diseases in higher vertebrates (3, 5).”
BackgroundStaphylococcus aureus lipid factors modulate melanoma cell clustering and invasion
Giese, M. A., Ramakrishnan, G., Steenberge, L. H., Dovan, J. X., Sauer, J., & Huttenlocher, A. (2024) · Disease Models & Mechanisms · doi:10.1242/dmm.050770 · Cited by 14
Yi, D., Li, T., Xiao, Y., Zhang, X., Hao, Q., Zhang, F., Qiu, T., Yang, G., Sun, X., Dong, Y., et al. (2024) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10728 · Cited by 16
“85,86 Wynder et al. used germ-free and conventional rats to study the effect of the gut microbiota on the sensitivity of the colon to the carcinogenic effects of 1,2-dimethylhydrazine, showing that only 20% of germ-free rats developed colonic tumors, whereas 93% of conventional rats developed…”
Li, H., Gong, Y., Yan, P., Xu, Y. J., Qin, G., Wen, W., & Teng, F. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1453753 · Cited by 23
“It has revealed the complex relationship between commensal bacteria and the host immune system (141, 142).”
Insights Into Heart-Tumor Interactions in Heart Failure
Caller, T., Moore, K. J., Lehmann, L., Wu, S. M., & Leor, J. (2025) · Circulation Research · doi:10.1161/circresaha.124.325490 · Cited by 15
Intestinal Organoids: A Model to Study the Role of Microbiota in the Colonic Tumor Microenvironment
Nalluri, H., Subramanian, S., & Staley, C. M. (2020) · Future Microbiology · doi:10.2217/fmb-2019-0345 · Cited by 13
Chiacchio, I. M. D., Gómez‐Abenza, E., Paiva, I. M., de Abreu, D. J. M., Rodriguez-Vidal, J. F., Carvalho, E. E. N., Carvalho, S. M., Murgas, L. D. S., & Mulero, V. (2022) · Scientific Reports · doi:10.1038/s41598-022-14245-3 · Cited by 13
Lu, S., Lin, J., Jin, J., Zhang, L., Guan, Y., Chen, H., Wu, Y., Zhang, W., & Luan, X. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2157402 · Cited by 13
“plays causal roles in the tumor progression [4,5], metastasis, and drug-resistance [6,7].”
BackgroundBlankestijn, J. M., Lopez‐Rincon, A., Neerincx, A. H., Vijverberg, S. J. H., Hashimoto, S., Gorenjak, M., Sardón‐Prado, O., Corcuera, P., Korta‐Murua, J., Pino-Yanes, M. D. M., et al. (2023) · Pediatric Allergy and Immunology · doi:10.1111/pai.13919 · Cited by 12
Tooth Loss Predicts Long-Term Prognosis of Esophageal Cancer After Esophagectomy
Miura, S., Nakamura, T., Hasegawa, T., Miura, Y., Takiguchi, G., Urakawa, N., Hasegawa, H., Yamamoto, M., Kanaji, S., Matsuda, Y., et al. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07903-w · Cited by 14
Editorial on "Cancer and the microbiota" published in Science.
Hamm, A. K., & Weir, T. L. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.07.16 · Cited by 16
Li, X., Jia, Y., Li, Y., Hei, H., Zhang, S., & Qin, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1582166 · Cited by 16
“In addition, intratumor microbiota have been implicated in in fl uencing both tumor initiation and metastatic processes (19).”
Interaction between the breast tumor microenvironment and gut microbiome
Tang, G., Millar, E. K. A., Graham, P., & Beretov, J. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2514136 · Cited by 15
“151 Interestingly, it has been proposed that certain drugs used in cancer therapy, such as doxorubicin, promote the formation of biofilms in vitro , 152 with the potential to inhibit cancer metastasis or even act as a vector for cancer therapies.”
Weis, A. M., Bauer, K. M., Tang, W. W., Victor, E. S., Bell, R. S., Brown, D. G., Ekiz, H. A., Tran, V., Klag, K. A., Swanson, E. A., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116172 · Cited by 16
Yan, C., Chen, Y., Tian, Y., Hu, S., Wang, H., Zhang, X., Chu, Q., Huang, S., & Sun, W. (2025) · Cellular Oncology · doi:10.1007/s13402-025-01103-3 · Cited by 14
Mørup, N., Main, A. M., Jørgensen, N., Daugaard, G., Juul, A., & Almstrup, K. (2022) · Andrology · doi:10.1111/andr.13305 · Cited by 13
Xu, S., Wang, H., Xia, C., Lv, J., & Zhang, G. (2022) · Pancreas · doi:10.1097/mpa.0000000000002143 · Cited by 16
Luo, L., Fu, A., Shi, M., Hu, J., Kong, D., Liu, T., Yuan, J., Sun, S., & Chen, C. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13020174 · Cited by 11
“It is currently believed that the ways in which microbes contribute to carcinogenesis fall into several categories: directly damaging host cell DNA, altering cell signaling pathways, modulating immune cells and inflammation, and influencing the metabolism of host-produced factors and pharmaceuticals [8].”
BackgroundZhuang, X., Li, B., Liu, X., Fan, T., Lan, X., Wang, X., & Yu, M. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.141982 · Cited by 12
Chi, M., Jiang, T., He, X., Peng, H., Li, Y., Zhang, J., Wang, L., Nian, Q., Ma, K., & Liu, C. (2023) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2023/3532756 · Cited by 13
“Rapid shifts in the composition and function of intestinal microbial communities, known as intestinal dysbiosis, are associated with intestinal barrier disruption and lead to the development of inflammatory [5], cancer [6], metabolic diseases [7], and neurodegenerative diseases [8].”
BackgroundMicrobiota as a New Target in Cancer Pathogenesis and Treatment
Algrafi, A., Jamal, A. A., & Ismaeel, D. M. (2023) · Cureus · doi:10.7759/cureus.47072 · Cited by 21
Emerging bacterial factors for understanding pathogenesis of endometriosis
Muraoka, A., Yokoi, A., & Kajiyama, H. (2023) · iScience · doi:10.1016/j.isci.2023.108739 · Cited by 18
Gut microbial dysbiosis in the pathogenesis of leukemia: an immune-based perspective
Goswami, M., & Bose, P. D. (2024) · Experimental Hematology · doi:10.1016/j.exphem.2024.104211 · Cited by 14
The impact of modulating the gastrointestinal microbiota in cancer patients
Morkūnas, E., Skiecevičienė, J., & Kupčinskas, J. (2020) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2020.101700 · Cited by 14
Intestinal Microbiota in Inflammatory Bowel Disease and Carcinogenesis: Implication for Therapeutics
Bruner, S., & Jobin, C. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.348 · Cited by 12
How the microbiome is shaping our understanding of cancer biology and its treatment
Gaines, S., Williamson, A. J., Hyman, N., & Kandel, J. J. (2017) · Seminars in Colon and Rectal Surgery · doi:10.1053/j.scrs.2017.09.003 · Cited by 12
Mechanisms underlying the effects of stress on tumorigenesis and metastasis (Review)
Zhang, Z., Wang, Y., & Li, Q. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4570 · Cited by 17
Costa, D. A., Monteiro, A., André, T. R., Esteves, S., Sargento, I., Ferreira, M., Alexandre, T., Clara, A. I., Freire, J., & Moreira, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.565036 · Cited by 12
Modulating the Inflammatory Response to Wounds and Cancer Through Infection
López‐Cuevas, P., Cross, S., & Martin, P. B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.676193 · Cited by 12
“the inflammatory response can be considerably altered by the local microbiome and by local, or systemic infection (Holder et al., 1997; Garrett, 2015; Dzutsev et al., 2017; Williams et al., 2017; Helmink et al., 2019; Janney et al., 2020).”
BackgroundPro-mutagenic effects of the gut microbiota in a Lynch syndrome mouse model
Pieters, W., Hugenholtz, F., Kos, K., Cammeraat, M., Moliej, T. C., Kaldenbach, D., Klarenbeek, S., Davids, M., Drost, L., de Konink, C., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2035660 · Cited by 15
“Additionally, indirect mechanisms of microbe-stimulated CRC development have been described, for example, by increased inflammation and proliferation.(5)”
BackgroundInfluentialAutophagy, microbiota and intestinal oncogenesis
Lévy, J., & Romagnolo, B. (2015) · Oncotarget · doi:10.18632/oncotarget.5966 · Cited by 12
Singla, R. K., & Bishayee, A. (2025) · Cancers · doi:10.3390/cancers17152507 · Cited by 14
Chen, J., Zhang, M., Gong, Y., Gu, Z., Zhou, H., Gu, Y., Shen, F., Zhou, G., & Ding, J. (2025) · Clinical Medicine Insights Oncology · doi:10.1177/11795549251380470 · Cited by 14
“31 The ,32-34 HPV infection is widely acknowledged as a primary etiological factor in cervical cancer.”
Markelova, N. N., Semenova, E. F., Синева, О. Н., & Sadykova, V. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911706 · Cited by 12
“Despite the fact that the implementation of these strategies causes minor damage to the host and is associated only with the possibility of the spread of microorganisms, the human microbiota is increasingly considered an inducer or modulator of pathological processes, including many forms of cancer [16].”
BackgroundBaik, J. E., Li, L., Shah, M. A., Freedberg, D. E., Jin, Z., Wang, T. C., & Han, Y. W. (2022) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0248 · Cited by 11
Crippa, V., Malighetti, F., Villa, M., Graudenzi, A., Piazza, R., Mologni, L., & Ramazzotti, D. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107064 · Cited by 12
Intratumoral microorganisms in tumors of the digestive system
Xuan, M., Gu, X., Liu, Y., Li, Y., Li, Y., Huang, D., Li, J., & Xue, C. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01425-5 · Cited by 13
Dysbiosis in Human Urinary Microbiota May Differentiate Patients with a Bladder Cancer
Vendrell, J. A., Cabello‐Aguilar, S., Senal, R., Heckendorn, E., Henry, S., Godreuil, S., & Solassol, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810159 · Cited by 12
“The interaction between microorganisms and their human hosts is highly intricate, influencing cancer development, progression, and response to treatment through various molecular mechanisms [6].”
BackgroundChen, Y., Wu, J., Cai, K., Xiao, X., Chen, Y., Zhang, X., Deng, S., Pei, C., Chen, Y., Xie, Z., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114283 · Cited by 11
Guo, Y., Xiao, Y., Zhang, C., Wang, Y., Cao, G., Tse, K. Y., Han, Z., Li, F., & Zhi, Y. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1574511 · Cited by 17
“Beyond the gut, microorganisms within tumors can in fl uence cancer development by inducing DNA mutations, promoting chronic in fl ammation, and activating the complement system (Garrett, 2015; Aykut et al., 2019; Pleguezuelos-Manzano et al., 2020).”
Gut microbiota and ovarian diseases: a new therapeutic perspective
Ju, S., Kang, Z., Yang, L., Xia, Y., Guo, Y. M., Li, S., Yan, H., Mao, Q., Wang, H. P., & Zhong, L. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01684-5 · Cited by 13
“Bacteria affect carcinogenesis in four ways: stimulating cell proliferation or death, disrupting immune system function, affecting host cell metabolism [88], and triggering genomic instability and DNA damage [89].”
Domingues, C., Cabral, C., Jarak, I., Veiga, F., Dourado, M., & Figueiras, A. (2023) · Vaccines · doi:10.3390/vaccines11030492 · Cited by 13
Microbiota regulation in constipation and colorectal cancer
Wang, L., Ruan, H., Wang, B., Qin, Y., & Zhong, W. (2023) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v15.i5.776 · Cited by 11
Cancerogenic parasites in veterinary medicine: a narrative literature review
Fonti, N., Parisi, F., Mancianti, F., Freer, G., & Poli, A. (2023) · Infectious Agents and Cancer · doi:10.1186/s13027-023-00522-x · Cited by 12
Ji, L., Zhang, H., Tian, G., Xi, S., Chu, Y., Zhang, Y., Liu, J., Ning, K., & Yang, J. (2023) · The Innovation Life · doi:10.59717/j.xinn-life.2023.100028 · Cited by 12
Biological Mechanisms for the Effect of Obesity on Cancer Risk: Experimental Evidence
Díaz, M. B., Herzig, S., & Schafmeier, T. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-42542-9_12 · Cited by 12
Ruggiero, M., & Aterini, S. (2015) · Springer eBooks · doi:10.1007/978-3-662-46875-3_1843 · Cited by 11
Single-cell multi-omics and machine learning for dissecting stemness in cancer
Huang, X., Huang, S., Reina, C., Šabanović, B., Roberto, M., Aicher, A., Tang, J., & Heeschen, C. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf566 · Cited by 13
Recent Advancements in Known and Emerging Risk Factors of Hepatocellular Carcinoma
Hussain, M. M., Bi, F., Wang, J., Zhai, A., Li, F., & Hu, H. (2025) · Cancer Medicine · doi:10.1002/cam4.71330 · Cited by 15
Li, X., Yuan, X., Zhu, X., Li, C., Ji, L., Lv, K., Tian, G., Ning, K., & Yang, J. (2023) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001744 · Cited by 11
Wang, Q., Wu, L., Zhang, Q., Wei, R., Meng, X., Han, X., Xing, N., Jiang, J., & Hu, H. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00610 · Cited by 11
Streptomyces Paradigm in Anticancer Therapy: A State-of-the Art Review
Sethi, Y., Vora, V., Anyagwa, O. E., Turabi, N., Abdelwahab, M. M., Kaiwan, O., Chopra, H., Attia, M. S., Yahya, G., Emran, T. B., et al. (2023) · Current Cancer Therapy Reviews · doi:10.2174/0115733947254550230920170230 · Cited by 10
Li, L., Zhong, H., Wang, Y., Pan, Z., Xu, S., Li, S. C., Zeng, G., Zhang, W., Li, J., & He, L. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1341032 · Cited by 10
“Furthermore, a growing body of evidence supports the close association between alterations in the composition of intestinal fl ora and the onset and progression of cancer (Schwabe and Jobin, 2013; Garrett, 2015).”
BackgroundWang, Q., Liu, Y., Chen, W., Chen, S., Su, M., Xie, X., Liu, W., Li, L., Zeng, L., Shi, Q., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12030573 · Cited by 13
“…tract cancer; in addition, intratumoral microbes may play a role in tumor growth and spread [35]. carcinogenic to humans comprise only It is estimated that cancer-associated microbes designated as carcinogenic to humans comprise only 10 of approximately 3.7 × 10 31 microbes on Earth [32].”
BackgroundInfluentialProgress in Biological Research and Treatment of Pseudomyxoma Peritonei
Li, X., Liu, G., & Wu, W. (2024) · Cancers · doi:10.3390/cancers16071406 · Cited by 15
“Microorganisms have been proven to influence the disease progression of a variety of tumors [80–82].”
BackgroundFeng, S., Zhang, Y. X., Wang, Y., Gao, Y., & Song, Y. (2024) · Chemistry - A European Journal · doi:10.1002/chem.202402485 · Cited by 14
Exploring micronutrients and microbiome synergy: pioneering new paths in cancer therapy
Bhatnagar, K., Jha, K., Dalal, N., Patki, N., Gupta, G., Kumar, A., Kumar, A., & Chaudhary, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1442788 · Cited by 12
“Through a variety of processes, including DNA damage and alterations in gene expression and tumor microenvironment (TME), immune system, and host metabolism, microorganisms can either stimulate or inhibit cell growth and metastasis (32).”
Exploring Microbial Signatures in Endometrial Tissues with Endometriosis
Guo, W., Xu, Z., Hu, S., & Shen, Y. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114072 · Cited by 13
Parthasarathy, S., Bupesh, G., Panigrahi, J., Konyak, L. M., Jamir, N., & Tharumasivam, S. V. (2025) · International review of neurobiology · doi:10.1016/bs.irn.2025.03.007 · Cited by 10
Ravegnini, G., Fosso, B., Ricci, R., Gorini, F., Turroni, S., Serrano, C., Pilco‐Janeta, D. F., Zhang, Q., Zanotti, F., Robertis, M. D., et al. (2022) · Cancer Science · doi:10.1111/cas.15441 · Cited by 10
Biomarkers of immunotherapy for non-small cell lung cancer
Shirasawa, M., Yoshida, T., & Ohe, Y. (2023) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyad134 · Cited by 11
Baliou, S., Adamaki, M., Spandidos, D. A., Kyriakopoulos, A. M., Christodoulou, I., & Zoumpourlis, V. C. (2018) · World Academy of Sciences Journal · doi:10.3892/wasj.2018.6 · Cited by 11
Ghanavati, R., Mohammadi, F., Javadi, A., Shahosseini, Z., Talebi, M., & Rohani, M. (2020) · PharmaNutrition · doi:10.1016/j.phanu.2020.100207 · Cited by 9
Zhang, C., Cui, X., Feng, L., Han, Z., Peng, D., Fu, W., & Xing, Y. (2021) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-21-71 · Cited by 10
“Intestinal microorganisms can lead to the occurrence of tumors by integrating oncogenes into the host genome, affecting the stability of the host genome, and breaking the balance between the host immune system (6).”
BackgroundLi, L., Deng, X., Zou, Y., Lv, X., & Guo, Y. (2021) · Brazilian Journal of Microbiology · doi:10.1007/s42770-021-00594-0 · Cited by 13
KDM1A Identified as a Potential Oncogenic Driver and Prognostic Biomarker via Multi-Omics Analysis
Li, L., Wang, Y., Mou, Y., Wu, H., & Ye, Q. (2021) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2021/4668565 · Cited by 9
“Microbial metabolites were proved to regulate the development of cancer via epigenetic regulators, such as propionic and butyric acids [49, 50].”
BackgroundLiu, G., Weston, C. Q., Pham, L. K., Waltz, S., Barnes, H., King, P. A., Sphar, D., Yamamoto, R. T., & Forsyth, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146064 · Cited by 10
A Concurrent Subtractive Assembly Approach for Identification of Disease Associated Sub-metagenomes
Han, W., Wang, M., & Ye, Y. (2017) · Lecture notes in computer science · doi:10.1007/978-3-319-56970-3_2 · Cited by 10
Gut microbes involvement in gastrointestinal cancers through redox regulation
Yangyanqiu, W., Chu, J., Yuqing, Y., Zhanbo, Q., & Han, S. (2023) · Gut Pathogens · doi:10.1186/s13099-023-00562-z · Cited by 10
Capozzi, V. A., Incognito, G. G., Scarpelli, E., Palumbo, M. A., Randazzo, C. L., Pino, A., Verde, M. L., Ronsini, C., Riemma, G., Gaiano, M., et al. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14040351 · Cited by 9
“In conclusion, while our study provides valuable insights into the potential link between OC and alterations in the genital microbiome, further research incorporating larger sample sizes, standardized methodologies, and longitudinal assessments is warranted to validate and expand upon our findings.”
ResultAndrogens in cervical cancer: Their role in epidemiology and biology
Gu, Y., Mu, Q., & Cheng, D. (2024) · iScience · doi:10.1016/j.isci.2024.110155 · Cited by 9
“52,53 The influence of the composition of the gut microbiota on the response to immune checkpoint inhibitors 54 and the ef-ficacy and toxicity of chemotherapeutic agents 55 also need to be taken into account, especially since these efficacy and toxicity show more pronounced differences in women.”
BackgroundHan, X., Zheng, J., Zhang, L., Zhao, Z., Cheng, G., Zhang, W., & Qu, P. (2024) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.15718 · Cited by 14
Microbial Biomarkers in Liquid Biopsy for Cancer: An Overview and Future Directions
Luo, F., Wang, X., Ye, C., & Sun, H. (2024) · Cancer Control · doi:10.1177/10732748241292019 · Cited by 14
Metadata
- Authors
- Garrett, W. S.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Garrett, Wendy S.
- ORCID
- Garrett, Wendy S.
- Venue
- Science
- Published
- 2015-04-03
- Volume
- 348
- Issue
- 6230
- Pages
- 80-86
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5535753
- OpenAlex
- W2073924079
- Cited by
- 1,404
- References
- 119
- Citations by year
- 2026: 145 · 2025: 169 · 2024: 169 · 2023: 151 · 2022: 162 · 2021: 141 · 2020: 127 · 2019: 106 · 2018: 77 · 2017: 68 · 2016: 58 · 2015: 29
- FWCI
- 7.49
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- NIH (R01CA154426)
- Burroughs Wellcome Career in Medical Sciences Award
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Keywords
- gut microbiota, cancer susceptibility, carcinogenesis, host-microbe interactions, cancer therapy response, cancer diagnosis
- MeSH terms
- Humans, Immunotherapy, Neoplasms, Carcinogenesis, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.